TCL Archive In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored October 24, 1997
TCL Archive Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.” October 29, 2004
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO. June 1, 2007
